Health
FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients – WebWire
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate…
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS). The device is intended to be used by prescription only as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older. The device, called Portable Neuromodulation Stimulator (PoNS), is a neuromuscular tongue stimulator that consists of a non-implantable apparatus…
-
Noosa News19 hours agoTributes for father Braiden Timmins and son Hendrix-hemi killed by ute in Regents Park, south of Brisbane
-
Noosa News14 hours agoUrgent warning to locals as multiple crews battle major industrial fire at Rocklea in Brisbane’s south
-
General23 hours agoWaiting them out. Australia’s Greater Sunrise Gas heist
-
Noosa News17 hours agoComing Soon: Marlowe